Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$9,043,186
+$2,278,378 QoQ
Shares Held
35,937
+15.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#972
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stratos Investment Management, LLC holds $63,598,115 across 8 Drug Manufacturers - General names. ABBV ranks #3 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,200 | $20,630,197 | |
| 2 | MRK |
Merck & Co., Inc.
|
147,259 | $18,922,781 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
35,937 | $9,043,186 | |
| 4 | AMGN |
Amgen Inc
|
23,940 | $8,669,152 | |
| 5 | JNJ |
Johnson & Johnson
|
20,901 | $5,308,226 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,199 | $404,161 | |
| 7 | PFE |
Pfizer Inc
|
13,853 | $333,580 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,978 | $286,832 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,043,186 | 35,937 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,764,808 | 31,104 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $6,363,903 | 27,852 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $6,287,005 | 27,153 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,995,034 | 26,910 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $5,331,236 | 25,445 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,223,204 | 12,511 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,383,978 | 12,072 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,064,586 | 12,037 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,002,917 | 10,999 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,058,621 | 13,284 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $2,019,017 | 13,545 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,694,768 | 12,579 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,842,317 | 11,560 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $1,878,877 | 11,626 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,579,249 | 11,767 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,001,035 | 13,065 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $2,132,881 | 13,157 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,706,175 | 12,601 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $1,180,960 | 10,948 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $952,596 | 8,457 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $800,070 | 7,393 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $1,059,177 | 9,885 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $753,098 | 8,598 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $637,679 | 6,495 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $341,712 | 4,485 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||